148 related articles for article (PubMed ID: 29666445)
1. p52 expression enhances lung cancer progression.
Saxon JA; Yu H; Polosukhin VV; Stathopoulos GT; Gleaves LA; McLoed AG; Massion PP; Yull FE; Zhao Z; Blackwell TS
Sci Rep; 2018 Apr; 8(1):6078. PubMed ID: 29666445
[TBL] [Abstract][Full Text] [Related]
2. Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.
Yeo SK; French R; Spada F; Clarkson R
Breast Cancer Res Treat; 2017 Apr; 162(3):465-477. PubMed ID: 28190248
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
[TBL] [Abstract][Full Text] [Related]
4. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
5. p52 Overexpression Increases Epithelial Apoptosis, Enhances Lung Injury, and Reduces Survival after Lipopolysaccharide Treatment.
Saxon JA; Cheng DS; Han W; Polosukhin VV; McLoed AG; Richmond BW; Gleaves LA; Tanjore H; Sherrill TP; Barham W; Yull FE; Blackwell TS
J Immunol; 2016 Feb; 196(4):1891-9. PubMed ID: 26773153
[TBL] [Abstract][Full Text] [Related]
6. A transgenic model reveals important roles for the NF-kappa B alternative pathway (p100/p52) in mammary development and links to tumorigenesis.
Connelly L; Robinson-Benion C; Chont M; Saint-Jean L; Li H; Polosukhin VV; Blackwell TS; Yull FE
J Biol Chem; 2007 Mar; 282(13):10028-10035. PubMed ID: 17261585
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Evaluation of Nuclear Factor-κΒ Expression Patterns in Non-Small Cell Lung Cancer.
Giopanou I; Lilis I; Papaleonidopoulos V; Marazioti A; Spella M; Vreka M; Papadaki H; Stathopoulos GT
PLoS One; 2015; 10(7):e0132527. PubMed ID: 26147201
[TBL] [Abstract][Full Text] [Related]
8. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE
Mol Cell Biol; 2005 Nov; 25(22):10136-47. PubMed ID: 16260626
[TBL] [Abstract][Full Text] [Related]
9. p52-Bcl3 complex promotes cyclin D1 expression in BEAS-2B cells in response to low concentration arsenite.
Wang F; Shi Y; Yadav S; Wang H
Toxicology; 2010 Jun; 273(1-3):12-8. PubMed ID: 20420878
[TBL] [Abstract][Full Text] [Related]
10. Oncogenes, tumor suppressors and p52 NF-kappaB.
Perkins ND
Oncogene; 2003 Oct; 22(48):7553-6. PubMed ID: 14576816
[TBL] [Abstract][Full Text] [Related]
11. Late-phase synthesis of IκBα insulates the TLR4-activated canonical NF-κB pathway from noncanonical NF-κB signaling in macrophages.
Chatterjee B; Banoth B; Mukherjee T; Taye N; Vijayaragavan B; Chattopadhyay S; Gomes J; Basak S
Sci Signal; 2016 Dec; 9(457):ra120. PubMed ID: 27923915
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
13. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
14. Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis.
Hufnagel DH; Wilson AJ; Saxon J; Blackwell TS; Watkins J; Khabele D; Crispens MA; Yull FE; Beeghly-Fadiel A
Biomark Res; 2020; 8():45. PubMed ID: 32974032
[TBL] [Abstract][Full Text] [Related]
15. Rescue of TRAF3-null mice by p100 NF-kappa B deficiency.
He JQ; Zarnegar B; Oganesyan G; Saha SK; Yamazaki S; Doyle SE; Dempsey PW; Cheng G
J Exp Med; 2006 Oct; 203(11):2413-8. PubMed ID: 17015635
[TBL] [Abstract][Full Text] [Related]
16. Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells.
Dejardin E; Bonizzi G; Bellahcène A; Castronovo V; Merville MP; Bours V
Oncogene; 1995 Nov; 11(9):1835-41. PubMed ID: 7478612
[TBL] [Abstract][Full Text] [Related]
17. Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway.
Roy P; Mukherjee T; Chatterjee B; Vijayaragavan B; Banoth B; Basak S
Oncogene; 2017 Mar; 36(10):1417-1429. PubMed ID: 27641334
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
Hu J; Colburn NH
Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway.
Eliopoulos AG; Caamano JH; Flavell J; Reynolds GM; Murray PG; Poyet JL; Young LS
Oncogene; 2003 Oct; 22(48):7557-69. PubMed ID: 14576817
[TBL] [Abstract][Full Text] [Related]
20. Processing of the NF-kappa B2 precursor p100 to p52 is critical for RANKL-induced osteoclast differentiation.
Maruyama T; Fukushima H; Nakao K; Shin M; Yasuda H; Weih F; Doi T; Aoki K; Alles N; Ohya K; Hosokawa R; Jimi E
J Bone Miner Res; 2010 May; 25(5):1058-67. PubMed ID: 19874202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
